Inato website screenshot

Inato

Inato is a Paris-based clinical trials technology company (founded 2016) operating an AI-powered marketplace that connects pharmaceutical sponsors, community research sites, and patients to run faster, more inclusive clinical trials. Sponsors post upcoming trials and site needs; the platform uses AI for site selection, feasibility, patient pre-screening, and enrollment optimization, giving the 95% of community-based research sites that historically run few trials a way to participate. The marketplace spans 6,000+ research sites across 50+ countries and is used by leading pharma sponsors. Inato is not a public API provider — it is a SaaS platform surfaced in the API Evangelist network as a company profile via the obvious-ventures portfolio.

Inato is profiled on the APIs.io network. Tagged areas include Company, Clinical Trials, Healthcare, Life Sciences, and Pharmaceuticals.

Inato’s developer surface includes documentation, support, engineering blog, signup flow, and 11 more developer resources.

27.6/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyClinical TrialsHealthcareLife SciencesPharmaceuticalsClinical ResearchMarketplaceArtificial Intelligence

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 27.6/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 4.8 / 20
Commercial Clarity 10.0 / 20
Operational Transparency 1.4 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/inato: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 3

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Inato Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Inato Vulnerability Disclosure

contact published

SECURITY

Inato Trust Center

ISO 27001, HIPAA, GDPR

SECURITY

Resources

Get Started 3

Portal, sign-up, and the first successful call

Documentation 1

Reference material describing how the API behaves

Access & Security 5

Authentication, authorization, and security posture

Operate 2

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: inato
name: Inato
description: Inato is a Paris-based clinical trials technology company (founded 2016) operating an AI-powered marketplace
  that connects pharmaceutical sponsors, community research sites, and patients to run faster, more inclusive clinical trials.
  Sponsors post upcoming trials and site needs; the platform uses AI for site selection, feasibility, patient pre-screening,
  and enrollment optimization, giving the 95% of community-based research sites that historically run few trials a way to
  participate. The marketplace spans 6,000+ research sites across 50+ countries and is used by leading pharma sponsors. Inato
  is not a public API provider — it is a SaaS platform surfaced in the API Evangelist network as a company profile via the
  obvious-ventures portfolio.
url: https://raw.githubusercontent.com/api-evangelist/inato/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- obvious-ventures
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/68c165ec9c8a75268ff69a2d/69b3a8be042ee81493120fc1_opengraph.jpg
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Clinical Trials
- Healthcare
- Life Sciences
- Pharmaceuticals
- Clinical Research
- Marketplace
- Artificial Intelligence
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://inato.com
- type: DeveloperPortal
  url: https://marketplace.inato.com/login
- type: Documentation
  url: https://support.inato.com/
- type: Support
  url: https://support.inato.com/
- type: HelpCenter
  url: https://support.inato.com/
- type: Blog
  url: https://www.inato.com/blogs
- type: SignUp
  url: https://marketplace.inato.com/login
- type: Login
  url: https://marketplace.inato.com/login
- type: TermsOfService
  url: https://www.inato.com/terms-conditions
- type: PrivacyPolicy
  url: https://www.inato.com/privacy-policy
- type: TrustCenter
  url: security/inato-trust-center.yml
- type: Compliance
  url: https://support.inato.com/data-security
- type: Security
  url: https://support.inato.com/data-security
- type: VulnerabilityDisclosure
  url: security/inato-vulnerability-disclosure.yml
- type: DomainSecurity
  url: security/inato-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence